MARKET

CUVL

CUVL

Clinuvl Phrmaceu
NASDAQ
5.27
+0.04
+0.67%
Opening 10:13 10/19 EDT
OPEN
5.24
PREV CLOSE
5.24
HIGH
5.40
LOW
5.24
VOLUME
1.77K
TURNOVER
--
52 WEEK HIGH
8.87
52 WEEK LOW
4.910
MARKET CAP
266.07M
P/E (TTM)
11.40
1D
5D
1M
3M
1Y
5Y
1D
Disc Medicine: Second To Market, Priced Like It's First
Seeking Alpha · 6d ago
Weekly Report: what happened at CUVL last week (1005-1009)?
Weekly Report · 10/12 10:41
Weekly Report: what happened at CUVL last week (0928-1002)?
Weekly Report · 10/05 10:40
Weekly Report: what happened at CUVL last week (0921-0925)?
Weekly Report · 09/28 10:34
Weekly Report: what happened at CUVL last week (0914-0918)?
Weekly Report · 09/21 10:34
Weekly Report: what happened at CUVL last week (0907-0911)?
Weekly Report · 09/14 10:40
Weekly Report: what happened at CUVL last week (0831-0904)?
Weekly Report · 09/07 10:32
5 Reasons To Buy Clinuvel Pharmaceuticals After Its Nasdaq Uplisting
Seeking Alpha · 09/02 15:12
More
About CUVL
Clinuvel Pharmaceuticals Limited is a specialty pharmaceutical company. It is focused on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening, acute disorders, as well as healthcare solutions for specialized populations. Its lead therapy, SCENESSE (afamelanotide 16mg), is approved for commercial distribution in Europe, the United States of America, Israel, and Australia as the first systemic photoprotective drug for the prevention of phototoxicity (anaphylactoid reactions and burns) in adult patients with erythropoietic protoporphyria (EPP). It has operations in Europe, Singapore, and the United States of America. It develops and manufactures NEURACTHEL (adrenocorticotropic hormone) in different formulations, to target neurological, endocrinological, and degenerative disorders. Its pharmaceutical product, PRENUMBRA, has been developed, and its use is to be expanded in the clinic from stroke to Parkinson's.

Webull offers Clinuvel Pharmaceuticals Ltd (ADR) stock information, including NASDAQ: CUVL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CUVL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CUVL stock methods without spending real money on the virtual paper trading platform.